Press release
Diabetes & Obesity Drug Development Pipeline Review and Market Report 2017
Market Research Report
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=877732
The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these indications. While products indicated for obesity do not currently have a large market presence, there are a large number of these products in the pipeline, with the majority in early stages of development.
The combined therapy area of diabetes and obesity presents a strong pipeline, accounting for a large proportion of the overall metabolic disorders therapy area. The majority of products are small molecules and biologics, which reflects the overall pharmacotherapeutic market trend.
An increasing pipeline presence for obesity-indicated products and overwhelming global media interest highlight the relevance of this indication and its future potential global revenues. However, the number of pharmacotherapeutic products for obesity is dwarfed by diabetes-indicated products. Given the status of obesity as a risk factor for T2DM, it is likely that the T2DM pipeline will continue to grow with the rising obesity incidence.
Scope
Which companies are the most active within the pipeline for diabetes and obesity?
Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
What are the most important R&D milestones and data publications to have occurred in this disease area?
Reasons to buy
Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication.
Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each.
Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these.
Understand the composition of the pipeline in terms of molecule type, molecular target, and mechanism of action and route of administration.
Table of Contents:
List of Tables
List of Figures
Diabetes and Obesity Report Coverage
Type 1 Diabetes (Juvenile Diabetes) Overview
Type 2 Diabetes Overview
Obesity Overview
Therapeutics Development by Stage
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Therapeutics under Development by Companies
Type 1 Diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Therapeutics under Investigation by Universities/Institutes
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Pipeline Products Glance
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Products under Development by Companies
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Products under Investigation by Universities/Institutes
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Companies Involved in Therapeutics Development
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Therapeutics Assessment
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Dormant Projects
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Discontinued Products
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Product Development Milestones
Type 1 diabetes (Juvenile Diabetes)
Type 2 Diabetes
Obesity
Read Full Report with TOC: http://www.marketresearchhub.com/report/diabetes-obesity-drug-development-pipeline-review-2016-report.html
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub
LinkedIn: https://www.linkedin.com/company/market-research-hub
Facebook: https://www.facebook.com/MarketResearchHub/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes & Obesity Drug Development Pipeline Review and Market Report 2017 here
News-ID: 492088 • Views: …
More Releases from Medical Research Report [MRH]
Huntington Disease - Pipeline Review, H1 2017: Clinical Trials Rise Due to Highe …
Market Research HUB's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H1 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.
Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include…
Global Video Laparoscopes Forecasted to Gain Steady Growth at a CAGR of 4.80% th …
In recent years, due to the growing technological advancements and the demand for minimally invasive surgeries is favorably supporting the growth of the video laparoscopes market significantly. Considering this positive impact on the market, a fresh study titled “MediPoint: Video Laparoscopes - Global Analysis and Market Forecasts” has been broadcasted to the vast online repository of Market Research Hub (MRH). This research study offers a detailed analysis of the market,…
Global Atherosclerosis Clinical Trials Rise Due to Higher Disease Incidences, H1 …
As per the findings of a latest study, growing incidence of heart attacks due to atherosclerosis or coronary heart disease is expected to increase demand for atherosclerosis treatment products. To overcome this issue, there are many clinical trials are in process. Market Research Hub (MRH) has recently published a latest market study to its vast repository, which is titled as “Atherosclerosis Global Clinical Trials Review, H1, 2017”. This 480-pages study…
Global Sleep Apnea Diagnostic Systems Sales Market Report: Share, Size, Key Tren …
The Market Research Hub’s report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Sleep Apnea Diagnostic Systems Sales Market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
